Compare CVLT & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVLT | PTCT |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.7B |
| IPO Year | 2006 | 2006 |
| Metric | CVLT | PTCT |
|---|---|---|
| Price | $127.22 | $80.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 17 |
| Target Price | ★ $139.53 | $80.65 |
| AVG Volume (30 Days) | 785.4K | ★ 1.7M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 264.48 |
| EPS | ★ 1.58 | N/A |
| Revenue | ★ $1,183,690,000.00 | $264,734,000.00 |
| Revenue This Year | $13.29 | N/A |
| Revenue Next Year | $13.20 | $17.70 |
| P/E Ratio | $82.30 | ★ N/A |
| Revenue Growth | 18.89 | ★ 36.19 |
| 52 Week Low | $71.75 | $43.18 |
| 52 Week High | $200.68 | $87.50 |
| Indicator | CVLT | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 64.44 | 66.11 |
| Support Level | $117.56 | $73.41 |
| Resistance Level | $129.23 | $87.50 |
| Average True Range (ATR) | 5.70 | 3.09 |
| MACD | -0.18 | 0.82 |
| Stochastic Oscillator | 62.23 | 92.01 |
CommVault Systems Inc provides cyber resiliency solutions designed to help the enterprise protect, secure, and recover its data, applications, and identity systems in a world of increasing cyber threats and attacks. Its offerings provide cyber resilience, including data protection, cyber recovery, data security, and governance, aiming to enable customers to continue business. The company delivers its solutions through Commvault Cloud, a cloud native platform that unifies data security, cyber recovery and identity resilience across on-premises, hybrid, multi-cloud, and software-as-a-service environments. It sells its offerings through subscription-based arrangements, including SaaS and term-based subscriptions, and also offers perpetual licenses, customer support, and professional services.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.